Ankyra Therapeutics, a clinical stage biotechnology company pioneering anchored therapy to treat cancer, today announced the first patient dosed in a visceral tumor in Part 2 of their dose escalation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback